MorphoSys Stock Quote MOR - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

18.61

Bid

18.40

Ask

20.62

Volume

71,300

18.46 Day's Range 18.70

0.00 52 Week Range 0.00

Market Cap

2.809B

Previous Close

18.65

Open

18.59

Last Trade

735

18.61

Last Trade Time

16:00:00

Financial Volume

$ 1,327,260

VWAP

18.6151

Average Volume (3m)

Shares Outstanding

150,620,548

Dividend Yield

PE Ratio

-58.16

Earnings Per Share (EPS)

-1.26

Revenue

238.28M

Net Profit

-189.73M

MorphoSys AG is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapies for people living with cancer and autoimmune diseases. MorphoSys is advancing its own pipeline of new drug candidates and has created antibodies that are developed by partners in di... MorphoSys AG is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapies for people living with cancer and autoimmune diseases. MorphoSys is advancing its own pipeline of new drug candidates and has created antibodies that are developed by partners in different areas of unmet medical need. Tremfya (guselkumab) - developed by Janssen Research & Development, LLC and marketed by Janssen Biotech, Inc. for the treatment of plaque psoriasis - became the first drug based on MorphoSys antibody technology to receive regulatory approval. The U.S. Food and Drug Administration granted accelerated approval of the company's proprietary product Monjuvi (tafasitamab-cxix) in combination with lenalidomide for patients with a certain type of lymphoma. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Biolog/vaccines

Website

www.morphosys.com

Headquarters

Munich, Deu

Founded

1992

MorphoSys AG is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MOR. The last closing price for MorphoSys was $18.65. Over the last year, MorphoSys shares have traded in a share price range of $ 0.00 to $ 0.00.

MorphoSys currently has 150,620,548 shares outstanding. The market capitalization of MorphoSys is $2.81 billion. MorphoSys has a price to earnings ratio (PE ratio) of -58.16.

Kuehn Law Encourages DM, SHCR, MOR, and ALE Investors to Contact Law Firm

Kuehn Law Encourages DM, SHCR, MOR, and ALE Investors to Contact Law Firm PR Newswire NEW YORK, July 8, 2024 NEW YORK, July 8, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law...

MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders

MorphoSys AG (FSE: MOR; NASDAQ: MOR) today announced that the company has entered into a delisting agreement with Novartis BidCo AG and Novartis AG following the successful closing of the...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
LGHLWLion Group Holding Ltd	$ 0.01 (26.60%)	52.48k
AKTXAkari Therapeutics PLC	$ 3.50 (24.56%)	540
NMHINatures Miracle Holding Inc	$ 0.4948 (18.86%)	221.63k
VVPRVivoPower International PLC	$ 3.03 (18.82%)	2.56M
AEHRAehr Test Systems	$ 14.27 (14.99%)	236.66k
HEPAHepion Pharmaceuticals Inc	$ 0.90 (-12.63%)	933
TXG10x Genomics Inc	$ 16.08 (-11.89%)	55.01k
LGMKLogicMark Inc	$ 0.60 (-10.18%)	36.56k
SXTP60 Degrees Pharmaceuticals Inc	$ 0.2215 (-9.07%)	108.08k
LZLegalZoom com Inc	$ 7.25 (-7.64%)	72.77k
MAXNMaxeon Solar Technologies Ltd	$ 0.2594 (4.60%)	6.86M
TCJHTop KingWin Ltd	$ 0.34 (-6.08%)	4.53M
PEGYPineapple Energy Inc	$ 2.465 (7.17%)	3.03M
MCACMonterey Capital Acquisition Corporation	$ 8.49 (-6.39%)	2.79M
NVDANVIDIA Corporation	$ 131.35 (-0.02%)	2.75M